ANG Lifesciences India Ltd FY26 Results Show Reduced Losses Amidst Financial Stress

ANG Lifesciences India Ltd reported a standalone loss of ₹4.73 crore for the fiscal year ended March 31, 2026, a reduction from ₹10.34 crore in FY25. The consolidated loss also decreased to ₹11.08 crore from ₹12.41 crore in the previous year.

Reader Takeaway: Reduced losses are positive, but bank defaults and governance gaps present significant risks.

What just happened

The company announced its audited financial results for FY26. Standalone revenue saw a marginal increase to ₹91.60 crore from ₹89.91 crore in FY25. Consolidated revenue remained stable at ₹92.89 crore. Despite revenue stability, the company continued to report losses, albeit reduced.

Why this matters

While the reduction in losses is a step in the right direction, the accompanying auditor remarks paint a concerning picture. Significant bank defaults and pending statutory dues point to potential liquidity issues. The absence of an internal auditor raises corporate governance concerns.

The backstory

ANG Lifesciences has been operating with financial pressures. The current results indicate a continued struggle to achieve profitability. The company's subsidiary, Mansa Print and Publishers Limited, also faces disputed income tax demands.

What changes now

Investors will closely watch the company's ability to manage its debt obligations and address the governance gaps. The ongoing financial strain may impact future growth prospects and operational stability.

Risks to watch

The auditor's report explicitly mentions defaults in interest and installment payments on borrowings from HDFC Bank, amounting to ₹25.86 crore. Unpaid statutory dues for over six months and pending disputed income tax demands are critical risks.

Peer comparison

While specific peer data for FY26 is not provided in the filing, the pharmaceutical and healthcare sector often sees companies balancing growth with significant debt. ANG Lifesciences' situation appears particularly stressed due to the auditor's specific remarks on defaults and statutory dues.

Context metrics (time-bound)

• FY26 Standalone Loss: ₹4.73 crore (Reduced from ₹10.34 crore in FY25)
• FY26 Consolidated Loss: ₹11.08 crore (Reduced from ₹12.41 crore in FY25)
• Bank Defaults (as of March 31, 2026): ₹25.86 crore
• Statutory Dues: Unpaid for over six months.

What to track next

Investors should monitor any announcements regarding the resolution of bank defaults, settlement of statutory dues, and the appointment of an internal auditor. Future financial results will be crucial in determining if the trend of reduced losses can be sustained and if profitability can be achieved.